# Alpha-blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men

> **NCT00700583** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 72 (actual)

## Conditions studied

- Nocturia

## Interventions

- **DRUG:** combination therapy of terazosin and hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00700583
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2011-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00700583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00700583, "Alpha-blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00700583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*